UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Oxidation state of the active-site cysteine in protein tyrosine phosphatase 1B

Nature (London), 2003-06, Vol.423 (6941), p.773-777

2003

Volltextzugriff (PDF)

An Irreversible Inhibitor of HSP72 that Unexpectedly Targets Lysine‐56

Angewandte Chemie International Edition, 2017-03, Vol.56 (13), p.3536-3540

International ed. in English, 2017

Volltextzugriff (PDF)

Drugging the PI3 Kinome: From Chemical Tools to Drugs in the Clinic

Cancer research (Chicago, Ill.), 2010-03, Vol.70 (6), p.2146-2157

2010

Volltextzugriff (PDF)

Scaffold-Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitors

Journal of chemical information and modeling, 2013-05, Vol.53 (5), p.1100-1112

2013

Volltextzugriff (PDF)

Discovery of a Chemical Probe Bisamide (CCT251236): An Orally Bioavailable Efficacious Pirin Ligand from a Heat Shock Transcription Factor 1 (HSF1) Phenotypic Screen

Journal of medicinal chemistry, 2017-01, Vol.60 (1), p.180-201

2017

Volltextzugriff (PDF)

Structure of the Epigenetic Oncogene MMSET and Inhibition by N‑Alkyl Sinefungin Derivatives

ACS chemical biology, 2016-11, Vol.11 (11), p.3093-3105

2016

Volltextzugriff (PDF)

Exploiting Protein Conformational Change to Optimize Adenosine-Derived Inhibitors of HSP70

Journal of medicinal chemistry, 2016-05, Vol.59 (10), p.4625-4636

2016

Volltextzugriff (PDF)

Structure-Based Design of Orally Bioavailable 1H‑Pyrrolo[3,2‑c]pyridine Inhibitors of Mitotic Kinase Monopolar Spindle 1 (MPS1)

Journal of medicinal chemistry, 2013-12, Vol.56 (24), p.10045-10065

2013

Volltextzugriff (PDF)

Structure-based design of molecular cancer therapeutics

Trends in biotechnology (Regular ed.), 2009-05, Vol.27 (5), p.315-328

2009

Volltextzugriff (PDF)

Aminopyrazine Inhibitors Binding to an Unusual Inactive Conformation of the Mitotic Kinase Nek2: SAR and Structural Characterization

Journal of medicinal chemistry, 2010-11, Vol.53 (21), p.7682-7698

2010

Volltextzugriff (PDF)

Achieving In Vivo Target Depletion through the Discovery and Optimization of Benzimidazolone BCL6 Degraders

Journal of medicinal chemistry, 2020-04, Vol.63 (8), p.4047-4068

2020

Volltextzugriff (PDF)

Application of Fragment Screening and Fragment Linking to the Discovery of Novel Thrombin Inhibitors

Journal of medicinal chemistry, 2006-02, Vol.49 (4), p.1346-1355

2006

Volltextzugriff (PDF)

Structure-Guided Evolution of Potent and Selective CHK1 Inhibitors through Scaffold Morphing

Journal of medicinal chemistry, 2011-12, Vol.54 (24), p.8328-8342

2011

Volltextzugriff (PDF)

Fragment-based screening maps inhibitor interactions in the ATP-binding site of checkpoint kinase 2

PloS one, 2013-06, Vol.8 (6), p.e65689-e65689

2013

Volltextzugriff (PDF)

A Degron Blocking Strategy Towards Improved CRL4CRBN Recruiting PROTAC Selectivity

Chembiochem : a European journal of chemical biology, 2023-12, Vol.24 (23), p.e202300351-e202300351

2023

Volltextzugriff (PDF)

Analysis of water patterns in protein kinase binding sites

Proteins, structure, function, and bioinformatics, 2011-07, Vol.79 (7), p.2109-2121

2011

Volltextzugriff (PDF)

Into Deep Water: Optimizing BCL6 Inhibitors by Growing into a Solvated Pocket

Journal of medicinal chemistry, 2021-12, Vol.64 (23), p.17079-17097

2021

Volltextzugriff (PDF)

Evaluation of APOBEC3B Recognition Motifs by NMR Reveals Preferred Substrates

ACS chemical biology, 2018-09, Vol.13 (9), p.2427-2432

2018

Volltextzugriff (PDF)

Rapid Discovery of Pyrido[3,4‑d]pyrimidine Inhibitors of Monopolar Spindle Kinase 1 (MPS1) Using a Structure-Based Hybridization Approach

Journal of medicinal chemistry, 2016-04, Vol.59 (8), p.3671-3688

2016

Volltextzugriff (PDF)

Benzimidazole Inhibitors Induce a DFG-Out Conformation of Never in Mitosis Gene A-Related Kinase 2 (Nek2) without Binding to the Back Pocket and Reveal a Nonlinear Structure−Activity Relationship

Journal of medicinal chemistry, 2011-03, Vol.54 (6), p.1626-1639

2011

Volltextzugriff (PDF)

Structure-based drug design: aiming for a perfect fit

Essays in biochemistry, 2017-11, Vol.61 (5), p.431-437

2017

Volltextzugriff (PDF)

Privileged Structures and Polypharmacology within and between Protein Families

ACS medicinal chemistry letters, 2018-12, Vol.9 (12), p.1199-1204

2018

Volltextzugriff (PDF)

1 – 25 von 75

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(72)
Mit Volltextzugriff
(70)

Publikationsform

Sprache

Englisch
(75)
Japanisch
(16)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(53)
Life Sciences & Biomedicine
(45)
Humans
(31)
Pharmacology & Pharmacy
(26)
Chemistry, Medicinal
(25)
Crystallography, X-Ray
(24)
Models, Molecular
(23)
Biochemistry & Molecular Biology
(16)
Structure-Activity Relationship
(16)
Protein Conformation
(15)
Binding Sites
(14)
Animals
(13)
Protein Kinase Inhibitors - Chemistry
(13)
Protein Kinase Inhibitors - Pharmacology
(11)
Chemistry
(9)
Drug Design
(9)
Molecular Structure
(9)
Protein Binding
(9)
Mice
(8)
Protein Structure, Tertiary
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Oxidation state of the active-site cysteine in protein tyrosine phosphatase 1B

An Irreversible Inhibitor of HSP72 that Unexpectedly Targets Lysine‐56

Drugging the PI3 Kinome: From Chemical Tools to Drugs in the Clinic

Scaffold-Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitors

Discovery of a Chemical Probe Bisamide (CCT251236): An Orally Bioavailable Efficacious Pirin Ligand from a Heat Shock Transcription Factor 1 (HSF1) Phenotypic Screen

Structure of the Epigenetic Oncogene MMSET and Inhibition by N‑Alkyl Sinefungin Derivatives

Exploiting Protein Conformational Change to Optimize Adenosine-Derived Inhibitors of HSP70

Structure-Based Design of Orally Bioavailable 1H‑Pyrrolo[3,2‑c]pyridine Inhibitors of Mitotic Kinase Monopolar Spindle 1 (MPS1)

Structure-based design of molecular cancer therapeutics

Aminopyrazine Inhibitors Binding to an Unusual Inactive Conformation of the Mitotic Kinase Nek2: SAR and Structural Characterization

Achieving In Vivo Target Depletion through the Discovery and Optimization of Benzimidazolone BCL6 Degraders

Application of Fragment Screening and Fragment Linking to the Discovery of Novel Thrombin Inhibitors

Structure-Guided Evolution of Potent and Selective CHK1 Inhibitors through Scaffold Morphing

Fragment-based screening maps inhibitor interactions in the ATP-binding site of checkpoint kinase 2

A Degron Blocking Strategy Towards Improved CRL4CRBN Recruiting PROTAC Selectivity

Analysis of water patterns in protein kinase binding sites

Into Deep Water: Optimizing BCL6 Inhibitors by Growing into a Solvated Pocket

Discovering cell-active BCL6 inhibitors: effectively combining biochemical HTS with multiple biophysical techniques, X-ray crystallography and cell-based assays

Evaluation of APOBEC3B Recognition Motifs by NMR Reveals Preferred Substrates

Rapid Discovery of Pyrido[3,4‑d]pyrimidine Inhibitors of Monopolar Spindle Kinase 1 (MPS1) Using a Structure-Based Hybridization Approach

Benzimidazole Inhibitors Induce a DFG-Out Conformation of Never in Mitosis Gene A-Related Kinase 2 (Nek2) without Binding to the Back Pocket and Reveal a Nonlinear Structure−Activity Relationship

Multiparameter Lead Optimization to Give an Oral Checkpoint Kinase 1 (CHK1) Inhibitor Clinical Candidate: (R)‑5-((4-((Morpholin-2-ylmethyl)amino)-5-(trifluoromethyl)pyridin-2-yl)amino)pyrazine-2-carbonitrile (CCT245737)

Structure-based drug design: aiming for a perfect fit

Privileged Structures and Polypharmacology within and between Protein Families

Suchergebnisse filtern